StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$117.80−1.29 (-1.08%)

Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –

Incyte operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Incyte's operating cash flow for the twelve months ending Sep 30, 2026 was $744.99M, down 40.5% year over year. For fiscal 2025 it was $1.41B, up 321.5% from the year before. Over ten years it grew 31.8% a year on average. The highest annual figure on record is $1.41B in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.41B+321.5%
FY2024Dec 31, 2024$335.34M-32.5%
FY2023Dec 31, 2023$496.49M-48.8%
FY2022Dec 31, 2022$969.94M+29.4%
FY2021Dec 31, 2021$749.49M–
FY2020Dec 31, 2020-$124.60M-117.5%
FY2019Dec 31, 2019$710.66M+111.4%
FY2018Dec 31, 2018$336.23M–
FY2017Dec 31, 2017-$92.99M-130.5%
FY2016Dec 31, 2016$304.76M+240.9%
FY2015Dec 31, 2015$89.41M+240.5%
FY2014Dec 31, 2014$26.26M+186.0%
FY2013Dec 31, 2013$9.18M–
FY2012Dec 31, 2012-$94.83M–
FY2011Dec 31, 2011-$161.72M-265.1%
FY2010Dec 31, 2010$97.94M+692.5%
FY2009Dec 31, 2009$12.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$675.32M-220.7%
Q2 FY2026Jun 30, 2026$507.66M+1034.7%
Q1 FY2026Mar 31, 2026$369.35M+38.8%
Q4 FY2025Dec 31, 2025$543.30M+42.5%
Q3 FY2025Sep 30, 2025$559.39M+79.9%
Q2 FY2025Jun 30, 2025$44.74M–
Q1 FY2025Mar 31, 2025$266.07M+21.6%
Q4 FY2024Dec 31, 2024$381.22M+158.1%
Q3 FY2024Sep 30, 2024$310.87M+110.3%
Q2 FY2024Jun 30, 2024-$575.56M-287.8%
Q1 FY2024Mar 31, 2024$218.81M–
Q4 FY2023Dec 31, 2023$147.73M-47.9%
Q3 FY2023Sep 30, 2023$147.84M-50.1%
Q2 FY2023Jun 30, 2023$306.53M+76.0%
Q1 FY2023Mar 31, 2023-$105.60M-148.9%
Q4 FY2022Dec 31, 2022$283.66M+145.9%
Q3 FY2022Sep 30, 2022$296.38M+16.2%
Q2 FY2022Jun 30, 2022$174.16M+0.7%
Q1 FY2022Mar 31, 2022$215.74M+4.7%
Q4 FY2021Dec 31, 2021$115.35M+7.5%
Q3 FY2021Sep 30, 2021$255.10M+40.1%
Q2 FY2021Jun 30, 2021$172.94M-35.8%
Q1 FY2021Mar 31, 2021$206.10M–
Q4 FY2020Dec 31, 2020$107.32M-18.5%
Q3 FY2020Sep 30, 2020$182.12M-32.7%
Q2 FY2020Jun 30, 2020$269.38M+76.1%
Q1 FY2020Mar 31, 2020-$683.42M-539.0%
Q4 FY2019Dec 31, 2019$131.62M+57.0%
Q3 FY2019Sep 30, 2019$270.42M+35.8%
Q2 FY2019Jun 30, 2019$152.96M+372.1%
Q1 FY2019Mar 31, 2019$155.66M+647.0%
Q4 FY2018Dec 31, 2018$83.84M–
Q3 FY2018Sep 30, 2018$199.15M+274.9%
Q2 FY2018Jun 30, 2018$32.40M-72.3%
Q1 FY2018Mar 31, 2018$20.84M–
Q4 FY2017Dec 31, 2017-$89.27M-194.6%
Q3 FY2017Sep 30, 2017$53.12M–
Q2 FY2017Jun 30, 2017$116.79M–
Q1 FY2017Mar 31, 2017-$173.64M–
Q4 FY2016Dec 31, 2016$94.38M–

More Incyte figures

See a number that looks wrong?